FDA-approved prescription digital therapeutic for pediatric ADHD (ages 8–12) — a clinically validated video game that uses adaptive sensory stimuli and motor challenges to directly treat attention deficits via neuroplasticity. Developed by Akili Interactive and backed by 5 clinical trials.